Hel Ved Capital Management’s Vicarious Surgical RBOT Stock Holding History

Hel Ved Capital Management’s Portfolio RBOT Stock Details RBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-43,487	Closed	-$771K	–	66
2023 Q3	$771K	Hold	43,487	–	–	0.25%	33
2023 Q2	$2.39M	Hold	43,487	–	–	0.88%	16
2023 Q1	$2.96M	Hold	43,487	–	–	1.47%	16
2022 Q4	$2.64M	Hold	43,487	–	–	1.49%	12
2022 Q3	$4.37M	Hold	43,487	–	–	3.36%	10
2022 Q2	$3.84M	Buy	+43,487	New	+$5.32M	2.35%	10
2021 Q4	$13M	Buy	+43,487	New	+$15.3M	8.48%	6
2021 Q1	$6.6M	Buy	+43,487	New	+$13.3M	5.65%	6

Other funds holding RBOT

VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return

MAMHA

MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return

DDD Partners Bellevue, Washington $1.45B AUM 9.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AMH

Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return

CFM

Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Hel Ved Capital Management's RBOT Position: Q4 2023 in Review

Hel Ved Capital Management sold out of Vicarious Surgical (RBOT) in Q4 2023, closing a stake of 43,487 shares — an estimated $771K sold.

Hel Ved Capital Management first reported a position in RBOT in Q1 2021 and held it in 8 quarters. The position peaked at $13M in Q4 2021. 72 funds tracked by Wall St. Rank hold RBOT as of Q4 2023.

Hel Ved Capital Management reported no remaining Vicarious Surgical position as of Q4 2023 after selling out during the quarter.
Hel Ved Capital Management sold 43,487 Vicarious Surgical shares in Q4 2023, an estimated $771K.
Hel Ved Capital Management first reported a position in Vicarious Surgical in Q1 2021 and held it in 8 quarters.
Hel Ved Capital Management's Vicarious Surgical position peaked at $13M in Q4 2021.
72 funds tracked by Wall St. Rank held Vicarious Surgical as of Q4 2023.

Based on Hel Ved Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.